Frank W. Chan
Executive VP & COOMr. Frank W. Chan, M.D., serves as Executive Vice President and Chief Operating Officer at Haemonetics Corporation from April 7, 2025. He serves as Director of Anesthesia Patient Safety Foundation. He served as President of Patient Monitoring of Medtronic plc. He is President of Medtronic's Patient Monitoring operating company. He leads an organization that is a partner to healthcare providers with technologies that improve patient outcomes, reduce healthcare costs and expand access to care. A researcher, innovator and business leader, he has years of experience in diverse leadership roles and has served on the editorial boards of clinical journals and has over 100 peer-reviewed publications. He is known for transforming organizations by aligning stakeholders to a common vision, meaningful strategies and global operating plans. He was serving as President of the Acute Care & Monitoring business. Prior to joining Medtronic, Mr. Chan held various leadership positions at Covidien plc from 2011 to 2015, where he played key roles across functions, including research and development and medical affairs. He is a champion of leadership development and inclusion in the workplace and believes that a culture rooted in trust and empathy drives innovation, collaboration and partnerships that enable the delivery of better care for patients.
Positions
- Company NameHaemonetics CorporationStock CodeHAEPositionExecutive VP & COOColleagues
- CAChristopher A. SimonCEO, President & Director
- EMEllen M. ZaneIndependent Chairman
- JCJames C. D'AreccaCFO, Executive VP & Financial Officer
- MLMichelle L. BasilExecutive VP, General Counsel & Secretary
- RGRoy GalvinExecutive VP & Chief Commercial Officer
- RERobert E. AbernathyIndependent Director
- LELloyd Emerson JohnsonIndependent Director
- MWMark W. KrollIndependent Director
